These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1235 related articles for article (PubMed ID: 7549046)

  • 21. A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.
    Carron CP; Meyer DM; Pegg JA; Engleman VW; Nickols MA; Settle SL; Westlin WF; Ruminski PG; Nickols GA
    Cancer Res; 1998 May; 58(9):1930-5. PubMed ID: 9581835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the cross-linking site of disintegrins albolabrin, bitistatin, echistatin, and eristostatin on isolated human platelet integrin GPIIb/IIIa.
    Calvete JJ; McLane MA; Stewart GJ; Niewiarowski S
    Biochem Biophys Res Commun; 1994 Jul; 202(1):135-40. PubMed ID: 8037704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins.
    McLane MA; Vijay-Kumar S; Marcinkiewicz C; Calvete JJ; Niewiarowski S
    FEBS Lett; 1996 Aug; 391(1-2):139-43. PubMed ID: 8706902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of cell-adhesive molecules.
    Saiki I; Iida J; Murata J; Ogawa R; Nishi N; Sugimura K; Tokura S; Azuma I
    Cancer Res; 1989 Jul; 49(14):3815-22. PubMed ID: 2736523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the novel murine monoclonal anti-von Willebrand factor (vWf) antibody GUR76-23 which inhibits vWf interaction with alpha IIb beta 3 but not alpha v beta 3 integrin.
    Yokoyama K; Handa M; Oda A; Katayama M; Fujimura Y; Murata M; Kawai Y; Watanabe K; Ikeda Y
    Biochem Biophys Res Commun; 1997 May; 234(1):147-52. PubMed ID: 9168979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
    Shahan TA; Ziaie Z; Pasco S; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
    Cancer Res; 1999 Sep; 59(18):4584-90. PubMed ID: 10493512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse antithrombotic assay. Inhibition of platelet thromboembolism by disintegrins.
    Beviglia L; Poggi A; Rossi C; McLane MA; Calabrese R; Scanziani E; Cook JJ; Niewiarowski S
    Thromb Res; 1993 Aug; 71(4):301-15. PubMed ID: 8236159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of glycoprotein IIb/IIIa blockade by flow cytometry with fluorescein isothiocyanate-conjugated crotavirin, a member of disintegrins.
    Liu CZ; Hur BT; Huang TF
    Thromb Haemost; 1996 Oct; 76(4):585-91. PubMed ID: 8903000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical characterization of the binding of echistatin to integrin alphavbeta3 receptor.
    Kumar CC; Nie H; Rogers CP; Malkowski M; Maxwell E; Catino JJ; Armstrong L
    J Pharmacol Exp Ther; 1997 Nov; 283(2):843-53. PubMed ID: 9353406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited T cell antigen receptor repertoire in tumor-infiltrating lymphocyte and inhibition of experimental lung metastasis of murine melanoma by anti-TCR antibody.
    Wang R; Taniguchi M
    J Immunol; 1995 Feb; 154(4):1797-803. PubMed ID: 7836764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregation.
    Sugimoto Y; Watanabe M; Oh-hara T; Sato S; Isoe T; Tsuruo T
    Cancer Res; 1991 Feb; 51(3):921-5. PubMed ID: 1988132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified heparins inhibit integrin alpha(IIb)beta(3) mediated adhesion of melanoma cells to platelets in vitro and in vivo.
    Zhang C; Liu Y; Gao Y; Shen J; Zheng S; Wei M; Zeng X
    Int J Cancer; 2009 Nov; 125(9):2058-65. PubMed ID: 19598263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystine-knot peptides engineered with specificities for α(IIb)β(3) or α(IIb)β(3) and α(v)β(3) integrins are potent inhibitors of platelet aggregation.
    Silverman AP; Kariolis MS; Cochran JR
    J Mol Recognit; 2011; 24(1):127-35. PubMed ID: 21194123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pentoxifylline inhibits integrin-mediated adherence of 12(S)-HETE and TNFalpha-activated B16F10 cells to fibronectin and endothelial cells.
    Jain M; Ratheesh A; Gude RP
    Chemotherapy; 2010; 56(1):82-8. PubMed ID: 20299795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional role of platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants.
    Mahalingam M; Ugen KE; Kao KJ; Klein PA
    Cancer Res; 1988 Mar; 48(6):1460-4. PubMed ID: 3345518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of prostacyclin on tumor cell-induced platelet aggregation.
    Menter DG; Onoda JM; Taylor JD; Honn KV
    Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An in vivo study of the role of the tumor cell cytoskeleton in tumor cell-platelet-endothelial cell interactions.
    Chopra H; Fligiel SE; Hatfield JS; Nelson KK; Diglio CA; Taylor JD; Honn KV
    Cancer Res; 1990 Dec; 50(23):7686-96. PubMed ID: 2253213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triflavin, an Arg-Gly-Asp-containing antiplatelet peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization.
    Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
    Jpn J Cancer Res; 1992 Aug; 83(8):885-93. PubMed ID: 1399825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.